Skip to Content


In the US, Iohexol (iohexol systemic) is a member of the drug class non-ionic iodinated contrast media and is used to treat Angiocardiography, Aortography, Arthrography, Body Imaging, Cerebral Arteriography, Cystourethrography, Digital Subtraction Angiography, Gastrointestinal Tract Examination, Head Imaging, Hysterosalpingography, Myelography, Peripheral Angiography, Urography and Visceral Arteriography.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Iodinated x-ray contrast media

Chemical Name

1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-

Foreign Names

  • Iohexolum (Latin)
  • Iohexol (German)
  • Iohexol (French)
  • Iohexol (Spanish)

Generic Names

  • Ioexolo (OS: DCIT)
  • Iohexol (OS: BAN, JAN, DCF, USAN)
  • Win 39424 (IS)
  • Iohexol (PH: BP 2016, JP XVI, Ph. Eur. 8, Ph. Int. 4, USP 38)
  • Iohexolum (PH: Ph. Eur. 8, Ph. Int. 4)

Brand Names

  • Accupaque
    Farmazak, Greece; GE Healthcare, Austria; GE Healthcare, Germany; GE Healthcare, Switzerland
  • ContaMedia Ioh
    Fresenius Kabi, Bulgaria
  • Hexascan
    Laboratorios Biosano, Chile
  • Iobrix
    Novamed, Turkey; Taejoon Pharm, Georgia; Taejoon Pharm, Thailand
  • Iohexagita
    Agfa Healthcare Imaging Agents, Germany
  • Iohexol Hikari Seiyaku
    Hikari Seiyaku, Japan
  • Iohexol Hovione
    Hovione, Portugal; Hovione FarmaCiencia S.A, Estonia
  • Iopaque
    Fuji Yakuhin, Japan
  • Iosol
    Towa Yakuhin, Japan
  • Ioverin
    Teva Seiyaku, Japan
  • Kopaq
    Onko-Koçsel, Turkey
  • Moiopaque
    Taisho Yakuhin, Japan
  • Nitigraf
    Juste, Spain
  • Omnipaque
    Amersham, Latvia; Amersham, Oman; Amersham Health, Spain; Daiichi Sankyo, Japan; GE, China; GE Healtcare, New Zealand; GE Healthcare, Bosnia & Herzegowina; GE Healthcare, Belgium; GE Healthcare, Bulgaria; GE Healthcare, Denmark; GE Healthcare, Estonia; GE Healthcare, Finland; GE Healthcare, France; GE Healthcare, Georgia; GE Healthcare, Greece; GE Healthcare, Croatia (Hrvatska); GE Healthcare, Hungary; GE Healthcare, Israel; GE Healthcare, Iceland; GE Healthcare, Italy; GE Healthcare, Lithuania; GE Healthcare, Malta; GE Healthcare, Netherlands; GE Healthcare, Norway; GE Healthcare, Poland; GE Healthcare, Romania; GE Healthcare, Serbia; GE Healthcare, Sweden; GE Healthcare, Slovenia; GE Healthcare, Tunisia; General Electric, Chile; HLB Pharma, Argentina; Nycomed, Oman; Opakim, Turkey; Sanofi Aventis, Brazil
  • Ou Su
    Yangtze River Pharma, China
  • Shuang Bei
    Beilu Pharmaceutical, China


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.